...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Liquidity
3
Aug 01, 2019 02:15PM
5
Aug 02, 2019 01:54AM

fouremm - DM has alluded to in the past that going public would happen when there was an event worthy of it.

2
Aug 02, 2019 02:59PM
3
Aug 02, 2019 03:06PM
4
Aug 03, 2019 12:57PM
3
Aug 03, 2019 02:55PM
2
Aug 03, 2019 02:56PM
Share
New Message
Please login to post a reply